|Day Low/High||11.10 / 12.58|
|52 Wk Low/High||6.64 / 12.83|
MiMedx Production Operations and Placenta Recovery Functions Operating Normally
Unparalleled Results of 60% healing at 12 Weeks and 71% Healing at 16 Weeks Expected to Expand VLU Insurance Coverage to an Additional $75 Million to $150 Million in annual Revenue Opportunity
MIMEDX TO HOST SHAREHOLDER CALL ON AUGUST 7, 2017 TO PRESENT THE STATUS OF VARIOUS CLINICAL STUDIES SUPPORTING ITS BIOPHARMACEUTICAL STRATEGY
Investors in MiMedx Group Inc saw new options become available today, for the March 2018 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Here's what moving in the world of Biotech
Q2 2017 REVENUE OF $76.4 MILLION IS 33% INCREASE OVER Q2 2016
The most recent short interest data has been released for the 06/30/2017 settlement date, which shows a 2,488,401 share decrease in total short interest for MiMedx Group Inc , to 20,263,818, a decrease of 10.94% since 06/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.
Investors in MiMedx Group Inc saw new options become available this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MDXG options chain for the new August 18th contracts and identified one put and one call contract of particular interest.
dHACM Allografts Retain Growth Factors And Bioactive Proteins Shown To Regulate Activity Of Cell Types, Including Stem Cells, That Are Critical To Orthopedic Repair Of Injured And Diseased Tissue
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.